Anthem Biosciences Ltd

{"amount":2}

{"description":"Anthem Biosciences debuted strongly, with shares rising 28% above the IPO price of ₹570, reflecting positive investor sentiment and strong market interest.","url":"https://www.thehindubusinessline.com/markets/stock-markets/anthem-biosciences-rally-31-over-570-ipo-price-on-listing-debut/article69837082.ece","sentiment":"Positive","domain":"Business Line"}

{"description":"Deven Choksey recommends \"Subscribe\" to the Anthem Biosciences Ltd IPO in its report dated July 14, 2025.","url":"https://www.moneycontrol.com/news/business/stocks/subscribe-for-anthem-biosciences-ltd-ipo-deven-choksey-13274301.html","sentiment":"Positive","domain":"moneycontrol.com"}

{"description":"Anthem Biosciences shares debuted at a 27% premium over their IPO price on Monday. The public offer raised Rs 3,395 crore.","url":"https://www.moneycontrol.com/news/business/ipo/anthem-biosciences-share-price-stock-lists-at-27pc-premium-over-ipo-price-on-nse-should-you-buy-sell-or-hold-13301275.html","sentiment":"Positive","domain":"moneycontrol.com"}

{"description":"Anthem Biosciences debuted on July 21 at ₹723.05 on NSE, up 26.85% from its IPO price, raising ₹3,395.79 crore with a subscription of 67.42 times.","url":"https://www.msn.com/en-in/money/markets/anthem-biosciences-shares-make-robust-debut-list-at-72305-on-nse-up-2685-from-ipo-price/ar-AA1IY674?ocid=BingNewsVerp","sentiment":"Positive","domain":"Mint on MSN"}

{"description":"Anthem Biosciences shares surged 28% on their market debut, closing with a market capitalization of Rs 41,017 crore.","url":"https://www.moneycontrol.com/news/business/ipo/anthem-biosciences-shares-close-with-28-gains-on-market-debut-valued-at-rs-41-017-crore-13303866.html","sentiment":"Positive","domain":"moneycontrol.com"}

{"description":"Anthem Biosciences shares rise post-IPO, aligning with Street estimates and grey market premium. Investors are considering whether to buy, sell, or hold the stock.","url":"https://www.msn.com/en-in/money/markets/anthem-biosciences-share-price-gains-after-strong-listing-should-you-buy-sell-of-hold-the-stock/ar-AA1IYyfG?ocid=BingNewsVerp","sentiment":"Positive","domain":"Mint on MSN"}

{"description":"Anthem Biosciences shares surged over 27% on NSE and BSE, trading at Rs. 730.70, up 1.05% from the listing price, marking a notable increase of 28.19%. Investors are keen to see future performance following this strong debut.","url":"https://www.goodreturns.in/news/anthem-biosciences-share-price-today-ipo-lists-at-26-premium-on-nse-bse-strong-debut-on-july-21-1443993.html","sentiment":"Positive","domain":"Goodreturns"}

{"description":"Anthem Biosciences shares debuted on the stock exchanges with a 27% premium over the IPO price. Investors are considering whether to buy, sell, or hold their shares following this strong market entry.","url":"https://www.moneycontrol.com/news/business/ipo/anthem-biosciences-share-price-stock-lists-at-27pc-premium-over-ipo-price-on-nse-should-you-buy-sell-or-hold-13301275.html","sentiment":"Positive","domain":"Moneycontrol"}

{"description":"Anthem Biosciences shares debuted with a 27% premium on the stock exchanges, reflecting strong growth and industry-leading margins, indicating that the IPO was fairly priced.","url":"https://www.cnbctv18.com/market/anthem-biosciences-ipo-listing-shares-debut-at-27-pc-premium-on-nse-bse-19640225.htm","sentiment":"Positive","domain":"CNBCTV18"}